本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

14.37
-0.0600-0.42%
盘后14.650.2800+1.95%17:25 EDT
成交量:136.79万
成交额:1,996.94万
市值:20.88亿
市盈率:-5.38
高:15.31
开:14.49
低:14.33
收:14.43
数据加载中...
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

重要事件披露

8-K - Current report
2021/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/02/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/10

重要事件披露

8-K/A [Amend] - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals